1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid has been researched along with Pancreatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baird, SK; Burvenich, I; De Vos, F; Dumolyn, C; Scott, AM; Staelens, S; Van Steenkiste, M; Vervoort, L; Waegemans, E | 1 |
1 other study(ies) available for 1-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid and Pancreatic Neoplasms
Article | Year |
---|---|
Preclinical evaluation of monoclonal antibody 14C5 for targeting pancreatic cancer.
Topics: Animals; Antibodies, Monoclonal; Drug Evaluation, Preclinical; Female; Humans; Iodine Radioisotopes; Mice; Mice, Nude; Pancreas; Pancreatic Neoplasms; Pentetic Acid; Radioimmunoassay; Radiopharmaceuticals; Receptors, Vitronectin; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |